BEST UNLIMITED TURBO LONG CERTIFICATE - MERCK & CO. Share Price

Certificat

AT68S

DE000SN4XHL8

Real-time Euronext Paris 10:23:47 03/05/2024 BST
7.858 EUR -1.59% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - MERCK & CO.
Current month-4.04%
1 month-4.18%
Date Price Change Volume
03/05/24 7.858 -1.59% 9
02/05/24 7.985 -4.04% 46
30/04/24 8.321 +0.54% 52
29/04/24 8.276 -2.56% 47
26/04/24 8.493 +3.06% 60

Real-time Euronext Paris

Last update May 03, 2024 at 10:23 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
AT68S
ISINDE000SN4XHL8
Date issued 14/07/2022
Strike 86.46 $
Maturity Unlimited
Parity 5 : 1
Emission price 3.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.86
Lowest since issue 1.706
Spread 0.233
Spread %2.92%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.3 USD
Average target price
141.6 USD
Spread / Average Target
+10.43%
Consensus
  1. Stock Market
  2. Certificates
  3. AT68S Certificat